COVERT: Impact of COVID-19 Pandemic on Orthopaedic Practice

Sponsor
Imperial College Healthcare NHS Trust (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05026788
Collaborator
(none)
5,000
1
25.4
196.6

Study Details

Study Description

Brief Summary

The COVERT Collaborative is led by a group of academic surgeons that is looking into the impact of the unprecedented COVID-19 pandemic on Trauma and Orthopaedic practice. This will involve both trauma and elective procedures, as well as mortality rates, operative and anaesthetic case mix. The information will help to shape service reconfiguration and enhance patient-specific treatment especially in the threat of potential subsequent waves and future pandemics.

Condition or Disease Intervention/Treatment Phase
  • Other: type of treatment

Detailed Description

In response to the health crisis, it is the responsibility of clinicians to audit and collaborate in order to observe the impact of the pandemic on clinical practice. With the restructure of the health infrastructure, there is likely to be changes to the nature of acute referrals to Trauma and Orthopaedics, operative and anaesthetic casemix, polytrauma and open fractures as well as the role of technology to reduce viral transmission. Patient safety ought to be prioritised at all times but a national narrative is required to equip healthcare services to counter the pandemic at various time intervals post-social distancing and lockdown at 1.5, 3, 6, 12, 18 and 24 months. This will act as an audit to compare and contrast if the reconfiguration of healthcare services is abiding by the governmental, DoH, NHS, WHO, RCS and BOA (BOAST) policies and guidelines.

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impact of COVID-19 Pandemic on Orthopaedic Practice: the COVid-19 Emergency/Elective Related Trauma (COVERT) Collaborative
Actual Study Start Date :
Mar 17, 2020
Actual Primary Completion Date :
Apr 30, 2020
Anticipated Study Completion Date :
Apr 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Intra-COVID lockdown

Any patients treated for orthopaedic trauma within the mandatory lockdown due to the pandemic.

Other: type of treatment
pathway of management for conservative treatment, operative treatment and type of anaesthesia used

Pre/post-COVID lockdown

Any patients treated for orthopaedic trauma either before or after the imposition of lockdown induced by the pandemic.

Other: type of treatment
pathway of management for conservative treatment, operative treatment and type of anaesthesia used

Outcome Measures

Primary Outcome Measures

  1. Treatment [duration of study]

    Non-operative vs operative management

  2. Mortality rate [duration of study]

    For patients presenting with orthopaedic trauma

  3. Number of COVID positive patients [duration of study]

    For patients presenting with orthopaedic trauma regardless of treatment pathway

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • anyone presenting with orthopaedic trauma to the Emergency Department who has been referred to the on-call Trauma and Orthopaedic team for further management.
Exclusion Criteria:
  • spinal trauma

Contacts and Locations

Locations

Site City State Country Postal Code
1 Imperial College Healthcare NHS Trust London United Kingdom

Sponsors and Collaborators

  • Imperial College Healthcare NHS Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kapil Sugand, Principal Investigator, Imperial College Healthcare NHS Trust
ClinicalTrials.gov Identifier:
NCT05026788
Other Study ID Numbers:
  • 1414607
First Posted:
Aug 30, 2021
Last Update Posted:
Oct 18, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2021